Vincent M Harisaran, MD | |
450 Veterans Memorial Pkwy, Bldg 14, East Providence, RI 02914-5300 | |
(401) 435-8488 | |
(401) 435-6694 |
Full Name | Vincent M Harisaran |
---|---|
Gender | Male |
Speciality | Urology |
Experience | 17 Years |
Location | 450 Veterans Memorial Pkwy, East Providence, Rhode Island |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1699977744 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | LP01080 (Rhode Island) | Secondary |
208800000X | Urology | CMD14133 (Rhode Island) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
The Miriam Hospital | Providence, RI | Hospital |
Rhode Island Hospital | Providence, RI | Hospital |
Southcoast Hospitals Group | Fall river, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Brown Urology, Inc. | 7810254513 | 30 |
News Archive
Jumping on that treadmill or bike is not only good for one's health, but also can help significantly reduce depression, researchers at UT Southwestern Medical Center have found.
A new analysis from Canada has found that cancer patients from poorer communities have a greater chance of dying prematurely than individuals from more affluent backgrounds even though cancer stage at time of diagnosis is similar across socioeconomic groups. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that efforts are needed to understand and reduce disparities in the survival of cancer patients from different socioeconomic groups.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that its Biologics License Application for ERWINAZE(R) has been accepted for filing and awarded Priority Review status by the U.S. Food and Drug Administration.
Last tuesday marked the conclusion of a patent trial involving discontinued trocar products by United States Surgical, a market leader and innovator of minimally invasive surgical instruments.
› Verified 8 days ago
Entity Name | The Miriam Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1831362813 PECOS PAC ID: 6901796408 Enrollment ID: O20081016000420 |
News Archive
Jumping on that treadmill or bike is not only good for one's health, but also can help significantly reduce depression, researchers at UT Southwestern Medical Center have found.
A new analysis from Canada has found that cancer patients from poorer communities have a greater chance of dying prematurely than individuals from more affluent backgrounds even though cancer stage at time of diagnosis is similar across socioeconomic groups. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that efforts are needed to understand and reduce disparities in the survival of cancer patients from different socioeconomic groups.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that its Biologics License Application for ERWINAZE(R) has been accepted for filing and awarded Priority Review status by the U.S. Food and Drug Administration.
Last tuesday marked the conclusion of a patent trial involving discontinued trocar products by United States Surgical, a market leader and innovator of minimally invasive surgical instruments.
› Verified 8 days ago
Entity Name | Brown Urology, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1467973099 PECOS PAC ID: 7810254513 Enrollment ID: O20171206000082 |
News Archive
Jumping on that treadmill or bike is not only good for one's health, but also can help significantly reduce depression, researchers at UT Southwestern Medical Center have found.
A new analysis from Canada has found that cancer patients from poorer communities have a greater chance of dying prematurely than individuals from more affluent backgrounds even though cancer stage at time of diagnosis is similar across socioeconomic groups. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that efforts are needed to understand and reduce disparities in the survival of cancer patients from different socioeconomic groups.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that its Biologics License Application for ERWINAZE(R) has been accepted for filing and awarded Priority Review status by the U.S. Food and Drug Administration.
Last tuesday marked the conclusion of a patent trial involving discontinued trocar products by United States Surgical, a market leader and innovator of minimally invasive surgical instruments.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Vincent M Harisaran, MD 450 Veterans Memorial Pkwy, Bldg 14, East Providence, RI 02914-5300 Ph: (401) 435-8488 | Vincent M Harisaran, MD 450 Veterans Memorial Pkwy, Bldg 14, East Providence, RI 02914-5300 Ph: (401) 435-8488 |
News Archive
Jumping on that treadmill or bike is not only good for one's health, but also can help significantly reduce depression, researchers at UT Southwestern Medical Center have found.
A new analysis from Canada has found that cancer patients from poorer communities have a greater chance of dying prematurely than individuals from more affluent backgrounds even though cancer stage at time of diagnosis is similar across socioeconomic groups. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that efforts are needed to understand and reduce disparities in the survival of cancer patients from different socioeconomic groups.
EUSA Pharma, a transatlantic specialty pharmaceutical company focused on oncology, oncology supportive care and critical care, today announced that its Biologics License Application for ERWINAZE(R) has been accepted for filing and awarded Priority Review status by the U.S. Food and Drug Administration.
Last tuesday marked the conclusion of a patent trial involving discontinued trocar products by United States Surgical, a market leader and innovator of minimally invasive surgical instruments.
› Verified 8 days ago
John F Maynard, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: Metacomet Office Park, 450 Veterans Parkway, East Providence, RI 02914 Phone: 401-435-8486 | |
Madeline Jones Cancian, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 450 Veterans Memorial Pkwy Bldg 14, East Providence, RI 02914 Phone: 401-453-6600 Fax: 401-435-6694 |